China National Biotec Moves Step Closer To Hong Kong IPO Clearance
This article was originally published in PharmAsia News
Executive Summary
China National Biotec Group moved a step closer to getting government approval to launch a $1.6 billion initial public offering on the Hong Kong Exchange.